GB201222576D0 - Method for diagnosing lung cancer - Google Patents

Method for diagnosing lung cancer

Info

Publication number
GB201222576D0
GB201222576D0 GBGB1222576.9A GB201222576A GB201222576D0 GB 201222576 D0 GB201222576 D0 GB 201222576D0 GB 201222576 A GB201222576 A GB 201222576A GB 201222576 D0 GB201222576 D0 GB 201222576D0
Authority
GB
United Kingdom
Prior art keywords
lung cancer
subject
methods
diagnosing lung
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GBGB1222576.9A
Other versions
GB2494580A (en
GB2494580B (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Swansea University
Original Assignee
Swansea University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Swansea University filed Critical Swansea University
Publication of GB201222576D0 publication Critical patent/GB201222576D0/en
Publication of GB2494580A publication Critical patent/GB2494580A/en
Application granted granted Critical
Publication of GB2494580B publication Critical patent/GB2494580B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
    • G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
    • G01N21/35—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57423—Specifically defined cancers of lung
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
    • G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
    • G01N21/35—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light
    • G01N2021/3595—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light using FTIR

Abstract

Provided are methods for diagnosing lung cancer in a subject or for identifying a subject at risk of developing lung cancer, the method comprising performing FTIR spectral analysis of a sputum sample obtained from the subject and comparing the spectrum produced from the sample with an FTIR spectrum from a normal control. Also provided are methods for detecting early and late stage cancer, methods for monitoring the progression of lung cancer in a subject and kits for use in the described methods.
GB1222576.9A 2010-07-02 2011-07-01 Method for diagnosing lung cancer Expired - Fee Related GB2494580B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB201011171A GB201011171D0 (en) 2010-07-02 2010-07-02 Method for diagnosing lung cancer
PCT/GB2011/000997 WO2012001370A1 (en) 2010-07-02 2011-07-01 Method for diagnosing lung cancer

Publications (3)

Publication Number Publication Date
GB201222576D0 true GB201222576D0 (en) 2013-01-30
GB2494580A GB2494580A (en) 2013-03-13
GB2494580B GB2494580B (en) 2017-05-10

Family

ID=42669106

Family Applications (2)

Application Number Title Priority Date Filing Date
GB201011171A Ceased GB201011171D0 (en) 2010-07-02 2010-07-02 Method for diagnosing lung cancer
GB1222576.9A Expired - Fee Related GB2494580B (en) 2010-07-02 2011-07-01 Method for diagnosing lung cancer

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GB201011171A Ceased GB201011171D0 (en) 2010-07-02 2010-07-02 Method for diagnosing lung cancer

Country Status (2)

Country Link
GB (2) GB201011171D0 (en)
WO (1) WO2012001370A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103760127B (en) * 2013-12-31 2016-08-17 浙江省林业科学研究院 The infrared identification method of true and false Radix Linderae tuber
GB201401055D0 (en) * 2014-01-22 2014-03-05 Univ Swansea Method for diagnosing lung diseases
WO2016097996A1 (en) 2014-12-16 2016-06-23 Ecole Polytechnique Federale De Lausanne (Epfl) Use of fourier transform infrared spectroscopy analysis of extracellular vesicles isolated from body fluids for diagnosing, prognosing and monitoring pathophysiological states and method therfor
WO2019113379A1 (en) 2017-12-06 2019-06-13 California Institute Of Technology System for analyzing a test sample and method therefor
GB201806002D0 (en) * 2018-04-11 2018-05-23 Univ Liverpool Methods of spectroscopic analysis
WO2021094703A1 (en) * 2019-11-15 2021-05-20 Beamline Diagnostics Limited Method for detecting lung cancer
GB202017340D0 (en) * 2020-11-02 2020-12-16 Univ Swansea Lung cancer diagnostic

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8208142B2 (en) * 2003-12-24 2012-06-26 King Salid University Lung cancer detection by optical analysis of body fluids

Also Published As

Publication number Publication date
GB201011171D0 (en) 2010-08-18
GB2494580A (en) 2013-03-13
WO2012001370A1 (en) 2012-01-05
GB2494580B (en) 2017-05-10

Similar Documents

Publication Publication Date Title
GB2494580A (en) Method for diagnosing lung cancer
WO2009037572A3 (en) Biomarker combinations for colorectal cancer
WO2014028884A3 (en) Cancer diagnostics using biomarkers
WO2013093635A3 (en) Plasma micrornas for the detection of early colorectal cancer
WO2015094995A3 (en) Gene signature biomarkers of tumor response to pd-1 antagonists
MX350533B (en) Pancreatic cancer biomarkers and uses thereof.
IN2013CN01129A (en)
WO2012047899A3 (en) Novel dna hypermethylation diagnostic biomarkers for colorectal cancer
NZ593514A (en) p-mTOR and p-AKT as Ratio Based Biomarkers for the Prognosis and/or Diagnosis of Cancer
WO2012170478A3 (en) Methods and kits for detecting adenomas, colorectal cancer, and uses thereof
WO2007109881A8 (en) Biomarkers useful for diagnosing prostate cancer, and methods thereof
GB2427468A (en) Devices and methods for enrichment and alteration of circulating tumour cells and other particles
WO2010033371A3 (en) Molecular markers for lung and colorectal carcinomas
MX355416B (en) Lung cancer biomarkers and uses thereof.
EP4242329A3 (en) Use of markers including filamin a in the diagnosis and treatment of prostate cancer
WO2014205184A3 (en) Classification system, methods and kit for classifying. predicting and treating breast cancer
WO2013036754A3 (en) Methods and compositions for diagnosis of ovarian cancer
WO2015094996A3 (en) Pd-l1 gene signature biomarkers of tumor response to pd-1 antagonists
WO2008097908A3 (en) Methods of diagnosing and prognosing lung cancer
WO2011085163A3 (en) Protein markers for lung cancer detection and methods of using thereof
WO2013057581A8 (en) Composite biomarker for non-invasive screening, diagnosis and prognosis of colorectal cancer
WO2010034794A3 (en) Methods and kits for the diagnosis and the staging of colorectal cancer
WO2015095862A3 (en) Microrna biomarkers for ovarian cancer
NZ751481A (en) Metabolite biomarkers for diseases associated with the contact activation system
WO2010009074A3 (en) Method for predicting and detecting tumor metastasis

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20210701